News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
511,001 Results
Type
Article (37421)
Company Profile (153)
Press Release (473427)
Multimedia
Podcasts (72)
Webinars (11)
Section
Business (150988)
Career Advice (1546)
Deals (29051)
Drug Delivery (107)
Drug Development (70321)
Employer Resources (128)
FDA (11881)
Job Trends (11399)
News (269469)
Policy (29569)
Tag
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
Academia (1973)
Accelerated approval (4)
Adcomms (21)
Allergies (74)
Alliances (46706)
ALS (71)
Alzheimer's disease (1228)
Antibody-drug conjugate (ADC) (115)
Approvals (11870)
Artificial intelligence (206)
Autoimmune disease (20)
Automation (9)
Bankruptcy (277)
Best Places to Work (8893)
BIOSECURE Act (19)
Biosimilars (96)
Biotechnology (78)
Bladder cancer (60)
Brain cancer (30)
Breast cancer (216)
Cancer (1830)
Cardiovascular disease (146)
Career advice (1304)
Career pathing (23)
CAR-T (117)
Cell therapy (327)
Cervical cancer (16)
Clinical research (57182)
Collaboration (777)
Compensation (459)
Complete response letters (25)
COVID-19 (2546)
CRISPR (39)
C-suite (189)
Cystic fibrosis (70)
Data (1735)
Decentralized trials (1)
Denatured (20)
Depression (39)
Diabetes (240)
Diagnostics (4098)
Digital health (10)
Diversity (4)
Diversity, equity & inclusion (35)
Drug discovery (101)
Drug pricing (109)
Drug shortages (31)
Duchenne muscular dystrophy (88)
Earnings (55630)
Editorial (40)
Employer branding (17)
Employer resources (114)
Events (69125)
Executive appointments (541)
FDA (12849)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (5)
Funding (549)
Gene editing (88)
Generative AI (15)
Gene therapy (277)
GLP-1 (749)
Government (4318)
Grass and pollen (5)
Guidances (45)
Healthcare (12648)
Huntington's disease (20)
IgA nephropathy (27)
Immunology and inflammation (101)
Indications (27)
Infectious disease (2691)
Inflammatory bowel disease (106)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (85)
Interviews (267)
IPO (12499)
IRA (44)
Job creations (2912)
Job search strategy (1127)
Kidney cancer (7)
Labor market (23)
Layoffs (370)
Leadership (13)
Legal (7856)
Liver cancer (58)
Lung cancer (265)
Lymphoma (128)
Machine learning (7)
Management (40)
Manufacturing (283)
MASH (62)
Medical device (6576)
Medtech (6579)
Mergers & acquisitions (17033)
Metabolic disorders (655)
Multiple sclerosis (63)
NASH (21)
Neurodegenerative disease (83)
Neuropsychiatric disorders (27)
Neuroscience (1697)
NextGen: Class of 2025 (4309)
Non-profit (2994)
Northern California (1923)
Now hiring (11)
Obesity (364)
Opinion (223)
Ovarian cancer (59)
Pain (69)
Pancreatic cancer (68)
Parkinson's disease (130)
Partnered (13)
Patents (203)
Patient recruitment (69)
Peanut (39)
People (41307)
Pharmaceutical (73)
Pharmacy benefit managers (16)
Phase I (17127)
Phase II (24963)
Phase III (19760)
Pipeline (1022)
Policy (145)
Postmarket research (2234)
Preclinical (7196)
Press Release (43)
Prostate cancer (90)
Psychedelics (30)
Radiopharmaceuticals (237)
Rare diseases (319)
Real estate (4131)
Recruiting (54)
Regulatory (19336)
Reports (23)
Research institute (1820)
Resumes & cover letters (226)
Rett syndrome (4)
RNA editing (3)
RSV (47)
Schizophrenia (74)
Series A (95)
Series B (48)
Service/supplier (6)
Sickle cell disease (46)
Southern California (1635)
Special edition (9)
Spinal muscular atrophy (148)
Sponsored (23)
Startups (2676)
State (2)
Stomach cancer (13)
Supply chain (65)
Tariffs (42)
The Weekly (50)
United States (16503)
Vaccines (735)
Venture capitalists (32)
Weight loss (269)
Women's health (16)
Worklife (11)
Date
Today (112)
Last 7 days (629)
Last 30 days (1989)
Last 365 days (25114)
2025 (8175)
2024 (26813)
2023 (30183)
2022 (39661)
2021 (42527)
2020 (40524)
2019 (33688)
2018 (25751)
2017 (25409)
2016 (24252)
2015 (28030)
2014 (22171)
2013 (18378)
2012 (19576)
2011 (20387)
2010 (18699)
Location
Africa (694)
Alabama (38)
Alaska (3)
Arizona (123)
Arkansas (7)
Asia (34029)
Australia (5467)
California (4332)
Canada (1581)
China (449)
Colorado (192)
Connecticut (187)
Delaware (119)
Europe (75224)
Florida (700)
Georgia (137)
Hawaii (1)
Idaho (33)
Illinois (383)
India (26)
Indiana (236)
Iowa (8)
Japan (139)
Kansas (77)
Kentucky (16)
Louisiana (11)
Maine (28)
Maryland (729)
Massachusetts (3331)
Michigan (116)
Minnesota (186)
Mississippi (1)
Missouri (57)
Montana (23)
Nebraska (12)
Nevada (41)
New Hampshire (27)
New Jersey (1374)
New Mexico (19)
New York (1320)
North Carolina (707)
North Dakota (6)
Northern California (1923)
Ohio (136)
Oklahoma (7)
Oregon (23)
Pennsylvania (964)
Puerto Rico (11)
Rhode Island (19)
South America (999)
South Carolina (11)
South Dakota (1)
Southern California (1635)
Tennessee (60)
Texas (570)
Utah (101)
Virginia (124)
Washington D.C. (46)
Washington State (367)
West Virginia (2)
Wisconsin (36)
511,001 Results for "cns pharmaceuticals ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CNS Pharmaceuticals Reports Full Year 2024 Financial Results
April 1, 2025
·
8 min read
Press Releases
Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders
April 7, 2025
·
10 min read
Press Releases
CNS Pharmaceuticals Announces Reverse Stock Split
February 19, 2025
·
4 min read
Press Releases
CNS Pharmaceuticals Announces Primary Analysis of Berubicin in Second Line Treatment of Glioblastoma Multiforme
March 26, 2025
·
8 min read
Press Releases
CNS Pharmaceuticals to Present at the BIO CEO & Investor Conference
February 10, 2025
·
2 min read
Press Releases
CNS Pharmaceuticals Provides Update on Current Cash Position and NASDAQ Listing
February 27, 2025
·
4 min read
Press Releases
CNS Pharmaceuticals to Present at 6th Glioblastoma Drug Development Summit
February 19, 2025
·
5 min read
Lone Star Bio
CNS Pharmaceuticals to Participate in the Virtual Investor Lunch Break: The CNSP Opportunity
CNS Pharmaceuticals, Inc. today announced that John Climaco, Chief Executive Officer of CNS Pharmaceuticals will present at the Virtual Investor Lunch Break: The CNSP Opportunity event on Tuesday, April 23, 2024 at 12:00 PM ET.
April 22, 2024
·
1 min read
Press Releases
CNS Pharmaceuticals to Present at the 18th Annual European Life Sciences CEO Forum
February 20, 2025
·
2 min read
Press Releases
CNS Pharmaceuticals, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
February 19, 2025
·
3 min read
1 of 51,101
Next
